FrancophonIA/ELRC3.0 huggingface dataset:
English: Sofosbuvir blocks the action of an enzyme (a type of protein) called ‘NS5B RNA-dependent RNA polymerase', velpatasvir targets a protein called ‘NS5A', while voxilaprevir blocks an enzyme called NS3/4A protease.
Slovenian: Sofosbuvir zavira delovanje encima (vrste beljakovine), imenovanega „RNK-polimeraza NS5B, odvisna od RNK“, velpatasvir je usmerjen proti beljakovini, imenovani „NS5A“, voksilaprevir pa zavira delovanje encima, imenovanega proteaza NS3/4A.
English: • rifampicin, rifabutin (antibiotics usually used to treat tuberculosis);
Slovenian: • rifampicin, rifabutin (antibiotika, ki se običajno uporabljata za zdravljenje tuberkuloze);
English: Why is Vosevi approved?
Slovenian: Zakaj je bilo zdravilo Vosevi odobreno?
English: For more information about treatment with Vosevi, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Vosevi preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: • rosuvastatin (medicine for lowering cholesterol in the blood);
Slovenian: • rosuvastatin (zdravilo za zniževanje holesterola v krvi);
English: This study is being carried out in light of data suggesting that patients treated with medicines belonging to the same class as Vosevi who have had liver cancer could be at risk of their cancer returning early.
Slovenian: Ta študija se izvaja na podlagi podatkov, ki kažejo, da pri bolnikih, zdravljenih z zdravili istega razreda, kot je zdravilo Vosevi, in predhodno obolelih za rakom jeter, obstaja tveganje zgodnje ponovitve raka.
English: The duration of treatment depends on whether patients have liver cirrhosis (scarring of the liver) or have received treatment with other direct-acting antivirals.
Slovenian: Trajanje zdravljenja je odvisno od tega, ali imajo bolniki cirozo jeter (brazgotinjenje jeter) ali pa so bili zdravljeni z drugimi neposredno delujočimi protivirusnimi zdravili.
English: Regarding safety, Vosevi was well tolerated with no major safety concern emerging.
Slovenian: Z vidika varnosti so bolniki zdravilo Vosevi dobro prenašali, pojavil pa se ni noben večji varnostni zadržek.
English: For practical information about using Vosevi, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Vosevi naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: By blocking these proteins, Vosevi stops the hepatitis C virus from multiplying and infecting new cells.
Slovenian: Zdravilo Vosevi z zaviranjem teh beljakovin prepreči virusu hepatitisa C, da bi se razmnoževal in okužil nove celice.
English: Vosevi is an antiviral medicine used to treat adults with chronic (long-term) hepatitis C, an infectious disease that affects the liver, caused by the hepatitis C virus (HCV).
Slovenian: Zdravilo Vosevi je protivirusno zdravilo, namenjeno zdravljenju odraslih s kroničnim (dolgotrajnim) hepatitisom C, tj. nalezljivo boleznijo, ki prizadene jetra in jo povzroča virus hepatitisa C (HCV).
English: For the full list of side effects and restrictions with Vosevi, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Vosevi glejte navodilo za uporabo.
English: • carbamazepine, phenobarbital, phenytoin (medicines for epilepsy);
Slovenian: • karbamazepin, fenobarbital, fenitoin (zdravila za zdravljenje epileptičnih napadov);
English: • ethinyl oestradiol-containing products (such as contraceptive medicines);
Slovenian: • zdravila, ki vsebujejo etinilestradiol (kot so kontraceptivi);
English: Vosevi can only be obtained with a prescription, and treatment should be started and monitored by a doctor experienced in the management of patients with hepatitis C virus infection.
Slovenian: Predpisovanje in izdaja zdravila Vosevi je le na recept, zdravljenje pa mora uvesti in spremljati zdravnik, ki ima izkušnje z zdravljenjem bolnikov, okuženih z virusom hepatitisa C.
English: In two further studies between 95 and 96% of Vosevi patients tested negative for the virus, compared with 96 to 98% of patients taking sofosbuvir/velpatasvir.
Slovenian: V dveh preostalih študijah je bil test za prisotnost virusa negativen pri 95 do 96 % bolnikov, ki so prejemali zdravilo Vosevi, pri bolnikih, ki so prejemali sofosbuvir/velpatasvir, pa je bilo bolnikov z negativnim testom od 96 do 98 %.
English: The active substances in Vosevi (sofosbuvir, velpatasvir and voxilaprevir) block three proteins essential for the hepatitis C virus to multiply.
Slovenian: Zdravilne učinkovine zdravila Vosevi (sofosbuvir, velpatasvir in voksilaprevir) zavirajo tri beljakovine, ki jih virus hepatitisa C potrebuje za razmnoževanje.
English: Additionally, Vosevi was shown to be very effective at eliminating the hepatitis C virus in patients in whom previous treatment with a NS5A inhibitor failed.
Slovenian: Poleg tega je bilo dokazano, da je zdravilo Vosevi zelo učinkovito pri odstranjevanju virusa hepatitisa C iz krvi bolnikov, pri katerih predhodno zdravljenje z zaviralcem NS5A ni bilo uspešno.
English: Vosevi has been shown in four main studies of 1,459 patients to be effective at clearing all six varieties (genotypes) of the hepatitis C virus, including in patients with liver cirrhosis and those who have previously tried other direct-acting antivirals.
Slovenian: V štirih glavnih študijah s 1 459 bolniki se je zdravilo Vosevi izkazalo za učinkovito pri odstranjevanju vseh šestih različic (genotipov) virusa hepatitisa C, tudi pri bolnikih s cirozo jeter in pri tistih, ki so bili prej zdravljeni z drugimi neposredno delujočimi protivirusnimi zdravili.
English: Over 96% of patients taking Vosevi in one study tested negative for HCV (their blood tests did not show any sign of the virus) after 12 weeks of treatment, compared with none of the patients who received placebo (a dummy treatment).
Slovenian: V eni od študij je bil test za prisotnost virusa hepatitisa C pri več kot 96 % bolnikov, ki so prejemali zdravilo Vosevi, po 12 tednih zdravljenja negativen (pri njihovih krvnih preiskavah ni bilo nobenega sledu o virusu), pri bolnikih, ki so prejemali placebo (zdravilo brez zdravilne učinkovine), pa bolnikov z negativnim testom ni bilo.
English: Over 97% of patients taking Vosevi in a second study tested negative, compared with 90% of patients taking only sofosbuvir/velpatasvir.
Slovenian: V drugi študiji je bil test negativen pri 97 % bolnikov, ki so prejemali zdravilo Vosevi, pri bolnikih, ki so prejemali samo sofosbuvir/velpatasvir, pa je bil test negativen pri 90 % bolnikov.
English: How is Vosevi used?
Slovenian: Kako se zdravilo Vosevi uporablja?
English: Vosevi contains the active substances sofosbuvir, velpatasvir and voxilaprevir.
Slovenian: Zdravilo Vosevi vsebuje zdravilne učinkovine sofosbuvir, velpatasvir in voksilaprevir.
English: The company that markets Vosevi will carry out a study in patients who previously have had liver cancer to evaluate the risk of liver cancer returning after treatment with direct-acting antivirals.
Slovenian: Družba, ki trži zdravilo Vosevi, bo za oceno tveganja ponovitve raka jeter po zdravljenju z neposredno delujočimi protivirusnimi zdravili izvedla študijo pri bolnikih, ki so preboleli raka jeter.
English: Vosevi has been shown to be highly effective in clearing the hepatitis C virus of all genotypes from the blood of both previously treated and untreated patients, including patients who have cirrhosis.
Slovenian: Zdravilo Vosevi se je izkazalo za visoko učinkovito pri odstranjevanju vseh genotipov virusa hepatitisa C iz krvi bolnikov, ki so bili predhodno zdravljeni, in tistih, ki niso bili, vključno z bolniki s cirozo.
English: How does Vosevi work?
Slovenian: Kako zdravilo Vosevi deluje?
English: • St John's wort (a herbal remedy used for depression and anxiety).
Slovenian: • šentjanževka (zdravilo rastlinskega izvora proti depresiji in anksioznosti).
English: • dabigatran etexilate (medicine for preventing blood clots);
Slovenian: • dabigatraneteksilat (zdravilo za preprečevanje krvnih strdkov);
English: The clinical relevance of these interactions is unknown.
Slovenian: Klinični pomen teh interakcij ni znan.
English: Each individual pack cannot be sold separately.
Slovenian: Posamezni zavitki se ne smejo prodajati ločeno.
English: These reactions were primarily transient in nature.
Slovenian: Reakcije so bile večinoma prehodne.
English: Epidemiological data between 1988 and 2003 indicated that in Europe coverage is lower and varies from country to country.
Slovenian: Epidemiološki podatki med letoma 1988 in 2003 so pokazali, da je pokritost v Evropi nižja in se od države do države razlikuje.
English: 2 micrograms
Slovenian: 2 mikrograma
English: The immunisation schedules for Prevenar should be based on official recommendations.
Slovenian: Imunizacijske sheme za Prevenar morajo temeljiti na uradnih priporočilih.
English: Effectiveness
Slovenian: Učinkovitost
English: F - 69007 Lyon
Slovenian: F - 69007 Lyon Francija
English: • CONDITIONS AND RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE
Slovenian: • POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO
English: These measures will help to protect the environment.
Slovenian: Takšni ukrepi pomagajo varovati
English: - if your child has a severe infection with a high temperature (over 38°C).
Slovenian: - če ima hujšo okužbo z zvišano telesno temperaturo (nad 38 °C).
English: WHO technical report No 927, 2005; Appendix serological criteria for calculation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
Slovenian: Tehnično poročilo SZO št. 927, 2005; Appendix serological criteria for calculation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
English: • Fever of 39°C or higher
Slovenian: • zvišana telesna temperatura 39 °C ali višja
English: Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom
Slovenian: Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ Velika Britanija
English: As the benefit of vaccination is high in this group of infants, vaccination should not be withheld or delayed.
Slovenian: Ker je korist cepljenja v tej skupini dojenčkov velika, cepljenja ne bi smeli odložiti ali ga izpustiti.
English: The vaccine works by helping the body to make its own antibodies, which protect your child against
Slovenian: Cepivo deluje tako, da pomaga telesu tvoriti lastna protitelesa, ki ščitijo vašega otroka pred naštetimi
English: Prevenar is not intended for use in adults.
Slovenian: Cepivo Prevenar ni namenjeno za uporabo pri odraslih.
English: The marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Slovenian: Imetnik dovoljenja za promet z zdravilom mora redno posodobljena poročila o varnosti zdravila za to zdravilo predložiti v skladu z zahtevami, določenimi v seznamu referenčnih datumov Unije (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES in objavljenem na evropskem spletnem
English: Upon storage, a white deposit and clear supernatant can be observed.
Slovenian: Med shranjevanjem lahko nastane bela usedlina in bister supernatant.
English: Antipyretic treatment should be initiated according to local treatment guidelines.
Slovenian: Antipiretično zdravljenje naj se izvaja v skladu z lokalnimi smernicami.
English: Unvaccinated infants and children over 7 months of age
Slovenian: Necepljeni dojenčki in otroci, starejši od 7 mesecev
English: Efficacy against pneumonia
Slovenian: Učinkovitost proti pljučnici
English: According to official recommendations in your country, an alternative schedule may be used by your health-care provider.
Slovenian: V skladu z uradnimi priporočili v vaši državi lahko vaš zdravstveni delavec uporabi kakšno drugačno shemo cepljenja.
English: Children were followed until 3.5 years of age.
Slovenian: Otroke so spremljali, dokler niso bili stari 3,5 leta.
English: For the number of doses to be administered in the different age groups, see section 4.2.
Slovenian: Glede števila odmerkov, ki so potrebni v različnih starostnih skupinah, glejte poglavje 4.2.
English: • You will be told when your child should come back for the next injection
Slovenian: • Povedali vam bodo, kdaj mora otrok prejeti naslednji odmerek.
English: The marketing authorisation holder must ensure that the system of pharmacovigilance presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the product is
Slovenian: Imetnik dovoljenja za promet z zdravilom mora zagotoviti, da bo sistem farmakovigilance, predstavljen v modulu 1.8.1 dovoljenja za promet z zdravilom, vzpostavljen in bo deloval, preden bo dal zdravilo v promet in toliko časa, kolikor bo zdravilo v uporabi.
English: These reactions were mostly moderate (less than or equal to 39 °C) and transient (see section 4.8).
Slovenian: Te reakcije so večinoma zmerne (39 °C ali manj) in prehodne (glejte poglavje 4.8).
English: Previously unvaccinated older infants and children:
Slovenian: Predhodno necepljeni starejši dojenčki in mali otroci:
English: The frequency is defined as follows: Very common(  1/10) Common ( 1/100 to < 1/10) Uncommon ( 1/1,000 to < 1/100) Rare ( 1/10,000 to < 1/1,000)
Slovenian: Pogostnost je opredeljena takole: zelo pogosti ( 1/10) pogosti ( 1/100 in < 1/10) občasni ( 1/1.000 in < 1/100) redki ( 1/10.000 in < 1/1.000) zelo redki (< 1/10.000)
English: Official batch release: in accordance with Article 114 of Council Directive 2001/83/EC as amended, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
Slovenian: Uradna sprostitev serije: v skladu s 114. členom dopolnjene in spremenjene Direktive 2001/83/ES, serijo uradno sprosti državni laboratorij ali laboratorij, določen v ta namen.
English: Pharmacotherapeutic group: pneumococcal vaccines, ATC code: J07AL02
Slovenian: Farmakoterapevtska skupina: cepiva proti pnevmokoknim infekcijam, oznaka ATC: J07AL02
English: The safety of the vaccine was assessed in different controlled clinical studies in which more than 18,000 healthy infants (6 weeks to 18 months) were included.
Slovenian: Podatki o varnosti cepiva izhajajo iz različnih kontroliranih kliničnih študij, v katere je bilo vključenih več kot 18.000 zdravih otrok (starih 6 tednov do 18 mesecev).
English: * Conjugated to the CRM197 carrier protein and adsorbed on aluminium phosphate (0.5 mg)
Slovenian: * vezan na CRM197 nosilni protein in adsorbiran na aluminijev fosfat (0,5 mg)
English: A subset of children in this study were followed until they reached 4 to 5 years of age.
Slovenian: Podskupino otrok v tej študiji so spremljali do njihovega 4. ali 5. leta starosti.
English: The majority of the safety experience comes from the efficacy trial in which 17,066 infants received 55,352 doses of Prevenar.
Slovenian: Večino podatkov o varnosti so dobili v študijah o učinkovitosti, v katere je bilo vključenih 17.066 otrok, ki so prejeli skupno 55.352 odmerkov cepiva Prevenar.
English: Antipyretic treatment should be initiated whenever warranted or when the temperature rises above 39°C.
Slovenian: Antipiretično zdravljenje pričnemo, kadar je upravičeno ali kadar je telesna temperatura višja od 39 °C.
English: • Erythema multiforme (a rash causing itchy red blotches)
Slovenian: • multiformni eritem (izpuščaj, ki povzroča srbeče rdeče lise)
English: CRM197, Activated Saccharides, and Conjugates Wyeth Pharmaceuticals, Division of Wyeth Holdings Corporation 4300 Oak Park
Slovenian: CRM197, aktivirani saharidi in konjugati Wyeth Pharmaceuticals, Division of Wyeth Holdings Corporation 4300 Oak Park
English: The expiry date refers to the last
Slovenian: Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
English: Due to the long-standing post marketing experience, the well characterised safety profile and the large exposure of the product the PRAC recommended to amend the PSUR frequency to 10-yearly and to amend Annex II accordingly to reflect the current QRD template sentence referring to the EURD list.
Slovenian: Odbor PRAC zaradi dolgotrajnih izkušenj iz obdobja trženja zdravila, dobro znanega varnostnega profila in velike izpostavljenosti zdravilu priporoča spremembo pogostnosti PSUR na 10 let in ustrezno spremembo Priloge II, da bo odražala stavek iz trenutne predloge QRD, ki se nanaša na seznam EURD.
English: - if your child is allergic (hypersensitive) to the active substances, to any other ingredients or to
Slovenian: - če je vaš otrok alergičen (preobčutljiv) na zdravilne učinkovine, na katerokoli drugo sestavino
English: No undesirable effects were reported in the majority of individuals.
Slovenian: V večini primerov niso poročali o neželenih učinkih.
English: Acute otitis media (AOM) is a common childhood disease with different aetiologies.
Slovenian: Akutno vnetje srednjega ušesa (AOM - acute otitis media) je pogosta otroška bolezen z različnimi etiologijami.
English: Please tell your doctor, nurse or pharmacist if your child is taking or has recently taken any other medicines including medicines obtained without prescription or has recently received any other vaccine.
Slovenian: Prosimo, povejte zdravniku, sestri ali farmacevtu, če vaš otrok jemlje ali je pred kratkim jemal katerokoli drugo zdravilo, tudi če ste ga dobili brez recepta, ali če je bil pred kratkim cepljen.
English: Medicines should not be disposed of via wastewater or household waste.
Slovenian: Cepiva ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
English: Efficacy against invasive disease was assessed in a large-scale randomised, double-blind, clinical trial in a multiethnic population in Northern California (Kaiser Permanente trial).
Slovenian: Učinkovitost proti invazivni bolezni je bila ugotovljena v veliki, randomizirani, dvojno slepi klinični študiji med večetničnim prebivalstvom v Severni Kaliforniji (študija Kaiser Permanente).
English: • A fourth injection (booster) will be given between 11 and 15 months of age
Slovenian: • Četrti (obnovitveni) odmerek bo prejel v starosti od 11 do 15 mesecev.
English: In older children receiving a single dose of vaccine, a higher rate of local reactions has been observed than that previously described in infancy.
Slovenian: Pri starejših otrocih, ki so dobili en sam odmerek cepiva, je bila pogostnost lokalnih reakcij večja, kot je bila predhodno opisana pri dojenčkih.
English: • Hypotonic-hyporesponsive episode (collapse or shock-like state)
Slovenian: • epizoda hipotonije in zmanjšane odzivnosti (kolaps ali šoku podobno stanje)
English: In Quebec, Canada Prevenar was introduced at 2, 4 and 12 months of age with a single dose catch-up programme in children up to 5 years of age.
Slovenian: V Quebecu v Kanadi so Prevenar uvedli v starosti 2, 4 in 12 mesecev s programom naknadnega cepljenja z enkratnim odmerkom otrok, starih do 5 let.
English: Preliminary data from England and Wales reported less than 1 year following introduction of routine immunisation at 2, 4 and 13 months with a single dose catch-up programme for children 13 to 23 months of age have suggested that effectiveness of this schedule might be lower against serotype 6B than against
Slovenian: Predhodni podatki iz Anglije in Walesa, o katerih so poročali manj kot 1 leto po uvedbi rutinskega cepljenja pri 2, 4 in 13 mesecih z naknadnim programom z enim samim odmerkom pri otrocih, starih 13 do 23 mesecev, so pokazali, da utegne biti učinkovitost te sheme manjša proti serotipu 6B kot proti
English: Detailed information on this medicine is available on the European Medicines Agency website:
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila:
English: WHAT PREVENAR IS AND WHAT IT IS USED FOR
Slovenian: KAJ JE CEPIVO PREVENAR IN ZA KAJ GA UPORABLJAMO
English: Also safety in previously unvaccinated older children has been assessed.
Slovenian: Ocenjeni so bili tudi podatki o varnosti pri starejših otrocih, ki niso bili
English: The pneumococcus is responsible for 30-40% of all bacterial AOM and a greater fraction of severe AOM.
Slovenian: Pnevmokoki so odgovorni za 30 % - 40 % vseh primerov bakterijskega AOM in za še večji delež težkega AOM.
English: Also contains sodium chloride and water for injections.
Slovenian: Vsebuje tudi natrijev klorid in vodo za injekcije.
English: The decrease in the incidence of IPD seen in older children may be partly due to naturally acquired immunity.
Slovenian: Zmanjšanje incidence invazivne pnevmokokne bolezni pri starejših otrocih je morda delno posledica naravno pridobljene imunosti.
English: Infants aged 6 weeks to 6 months of age
Slovenian: Dojenčki, stari od 6 tednov do 6 mesecev
English: The doctor or nurse will inject the recommended dose (0.5 ml) of the vaccine into your child's arm or leg muscle.
Slovenian: Zdravnik ali sestra bo otroku injiciral priporočeni odmerek cepiva (0,5 ml) v mišico na roki ali nogi.
English: Official Medicines Control Laboratory (OMCL) Agence Française de Sécurité Sanitaire des Produits de Santé Direction des laboratoires et des contrôles Avenue Jean Jaurès, 321
Slovenian: Uradni kontrolni laboratorij za zdravila (Official Medicines Control Laboratory - OMCL) Agence Française de Sécurité Sanitaire des Produits de Santé Direction des laboratoires et des contrôles
English: Vaccine effectiveness against IPD caused by vaccine serotypes was evaluated in 3- to 59-month old children within the first four years of the implementation of the programme.
Slovenian: Učinkovitost cepiva proti IPD, povzročenim s serotipi, vključenimi v cepivo, so ovrednotili pri otrocih, starih od 3 mesece do 59 mesecev, v prvih štirih letih izvajanja programa.
English: It is estimated that more than 80 % of the antimicrobial resistant strains would be covered by the serotypes included in the vaccine.
Slovenian: Ocenjujejo, naj bi bilo več kot 80 % na antibiotike odpornih sevov pokritih s serotipi, ki so vključeni v cepivo.
English: Theoretically, Prevenar could prevent about 6080% of serotypes causing pneumococcal AOM.
Slovenian: Teoretično bi Prevenar lahko preprečil okrog 60 % - 80 % serotipov, ki povzročajo pnevmokokno AOM.
English: In all studies, Prevenar was administered concurrently with the recommended childhood vaccines.
Slovenian: V vseh študijah so uporabljali cepivo Prevenar skupaj s priporočenimi cepivi za otroke.
English: At the booster, some suppression of Hib antibody level was observed but all children had protective levels.
Slovenian: Po poživitvenem odmerku so opazili nekoliko zmanjšan titer protiteles proti bakteriji Hib, vendar so imeli vsi otroci potrebno zaščitno raven protiteles.
English: Antibody concentrations were similar to those achieved following a three-dose infant series and a booster dose at less than 2 years of age.
Slovenian: Koncentracije protiteles so bile podobne tistim, ki so jih dosegli po zaporedju treh odmerkov za dojenčke in poživitvenem odmerku pri otrocih, mlajših od 2 let.
English: At the time of the study, the serotypes included in the vaccine accounted for 89 % of IPD.
Slovenian: V času študije so serotipi v cepivu vključevali 89 % povzročiteljev IPD.
English: Human data on the use during pregnancy or lactation and animal reproduction studies are not available.
Slovenian: Podatki o uporabi med nosečnostjo ali dojenjem pri človeku in podatki iz študije vplivov na sposobnost razmnoževanja pri živalih niso na
English: It will not protect against other infectious agents that can cause
Slovenian: Ne zaščiti pa pred drugimi povzročitelji okužb, ki
English: A minor infection, such as a cold, should not be a problem.
Slovenian: Vendar pa blažja okužba, kot je prehlad, ni razlog za odložitev
English: Estimates of efficacy against invasive disease were obtained in the US population where vaccine serotype coverage ranged from 80 to 89 %.
Slovenian: Oceno o učinkovitosti proti invazivnim okužbam so dobili med ameriškim prebivalstvom, kjer v cepivo vključeni serotipi tvorijo od 80 % do 89 % vseh primerov okužb.